{
  "folder": "IC-188",
  "content": "{{knowledge objective\n|Identifiant=OIC-188-20-A\n|Item_parent=Hypersensitivity and respiratory allergies in children and adults. Asthma, rhinitis\n|Item_parent_short=Hypersensitivity and respiratory allergies in children and adults. Asthma, rhinitis\n|Rank=A\n|Title=Knowing how to initiate emergency treatment of an asthma attack in children and adults.\n|Description=Emergency oxygen therapy (item 359), systemic corticosteroid therapy and bronchodilators (inhaled beta-mimetics, anticholinergics) and assessing efficacy.\n|Rubric=Management\n|Contributors=\n|Order=20}}\nTreatment of exacerbations is based on\n\no The use of inhaled BDCA (metered-dose aerosol in outpatients, nebulisation in the case of hospitalisation)\n\no Systemic corticosteroid therapy (0.5 to 1mg/kg/d for 5 days, PO or IV)\n\no Use of a nebulised anticholinergic (ipratropium) in the event of severe exacerbation.\n\no Oxygen therapy and/or ventilatory assistance should be discussed in the event of severe exacerbation (in intensive care).",
  "question": {
    "question": "What is the primary approach to treating exacerbations of asthma?",
    "option_a": "Intravenous administration of systemic corticosteroids as the first line of treatment",
    "option_b": "Use of inhaled bronchodilators and systemic corticosteroid therapy",
    "option_c": "Administration of oxygen therapy and/or ventilatory assistance as the initial treatment",
    "option_d": "Nebulisation of anticholinergics as the primary treatment for severe exacerbations",
    "correct_option": "B"
  }
}